Literature DB >> 7565465

Effects of parathyroidectomy on left ventricular mass in patients with hyperparathyroidism.

S Sato1, M Ohta, Y Kawaguchi, H Okada, M Ono, H Saito, M Utsunomiya, T Tamura, K Sugimoto, S Takamizawa.   

Abstract

The effects of parathyroidectomy on left ventricular muscle volume and mechanical performance were evaluated echocardiographically in 24 patients with secondary hyperparathyroidism due to chronic renal failure and in 7 with primary hyperparathyroidism. Intraventricular septum and posterior wall thickness, left ventricular end-diastolic diameters, shortening fraction, ejection fraction, and left ventricular mass index were measured by M mode recording by the parasternal short axis view prior to parathyroidectomy as baseline and repeated 12 months after parathyroidectomy. Serum basal carboxyterminal parathyroid hormone levels in patients with secondary hyperparathyroidism (34.4 +/- 13.7 ng/ml) were significantly higher than in those with primary hyperparathyroidism (3.4 +/- 5.1 ng/ml; p < 0.0001). At 12 months after parathyroidectomy, intraventricular septum and posterior wall thickness, left ventricular end-diastolic diameter and left ventricular mass index were reduced from 11.8 +/- 3.1 mm, 10.9 +/- 1.7 mm, 53.8 +/- 6.3 mm, 200.8 +/- 57.1 g/m2 to 10.0 +/- 2.1 mm (p < 0.05), 9.8 +/- 1.9 mm (p < 0.05), 50.7 +/- 7.2 mm (p < 0.05), 149.6 +/- 38.7 g/m2 (p < 0.0001), in patients with secondary hyperparathyroidism. In patients with primary hyperparathyroidism, all echocardiographic parameters remained in the normal range and did not show any significant changes before or after parathyroidectomy. From this study, parathyroid hormone at extremely high concentrations as seen in secondary hyperparathyroidism appears to be a cardiotoxic substance. Therefore, all patients with secondary hyperthyroidism should be examined by echocardiography and parathyroidectomy should be considered if myocardial hypertrophy is present.

Entities:  

Mesh:

Year:  1995        PMID: 7565465

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  6 in total

1.  Parathyroid hormone is related to QT interval independent of serum calcium in patients with coronary artery disease.

Authors:  Nicholas O Palmeri; Karina W Davidson; William Whang; Ian M Kronish; Donald Edmondson; Marcella D Walker
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-09-26       Impact factor: 1.468

2.  Multicenter study on parathyroidectomy (PTX) in Italy: preliminary results.

Authors:  Sandro Mazzaferro; Lida Tartaglione; Carmelo Cascone; Nicola Di Daniele; Antonello Pani; Massimo Morosetti; Marco Francisco; Maurizio Nordio; Maria Leonardi; Mauro Martello; Cristina Grimaldi; Mario Cozzolino; Silverio Rotondi; Marzia Pasquali
Journal:  J Nephrol       Date:  2018-08-28       Impact factor: 3.902

3.  Effect of intermittent versus continuous parathyroid hormone in the cardiovascular system of rats.

Authors:  Sanela Smajilovic; Rasmus Schaal-Jensen; Reza Jabbari; Una Smajilovic; Stig Haunso; Jacob Tfelt-Hansen
Journal:  Open Cardiovasc Med J       Date:  2010-03-31

Review 4.  Effect of Parathyroidectomy Upon Left Ventricular Mass in Primary Hyperparathyroidism: A Meta-Analysis.

Authors:  Donald J McMahon; Angela Carrelli; Nick Palmeri; Chiyuan Zhang; Marco DiTullio; Shonni J Silverberg; Marcella D Walker
Journal:  J Clin Endocrinol Metab       Date:  2015-10-07       Impact factor: 5.958

Review 5.  CKD-MBD: impact on management of kidney disease.

Authors:  Hiroaki Ogata; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa
Journal:  Clin Exp Nephrol       Date:  2007-12-21       Impact factor: 2.801

Review 6.  Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome.

Authors:  Suree Lekawanvijit
Journal:  Toxins (Basel)       Date:  2018-09-01       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.